Skip to main navigation Skip to search Skip to main content

Effects of Pergolide Treatment on Metabolic and Immunological Function in Horses with Pituitary Pars Intermedia Dysfunction (PPID)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/17 → 1/1/19

Funding

  • Boehringer Ingelheim Vetmedica: $79,731.00